What are the treatment options for a 46-year-old female with adenomyosis and pelvic pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Adenomyosis in a 46-Year-Old Female with Pelvic Pain

Medical management should be the first-line treatment for adenomyosis-related pelvic pain in a 46-year-old female, with surgical options reserved for cases refractory to medical therapy. 1, 2, 3

Diagnosis Confirmation

Before initiating treatment, confirm adenomyosis diagnosis with:

  • Transvaginal ultrasound (TVUS): First-line imaging modality with findings including:

    • Heterogeneous myometrium
    • Asymmetric myometrial thickening
    • Myometrial cysts
    • Linear striations
    • Ill-defined endometrial-myometrial border 4, 5
  • MRI: Consider if TVUS is inconclusive or for surgical planning 2, 3

Treatment Algorithm

Step 1: Medical Management (First-Line)

  1. Hormonal Options:

    • Levonorgestrel-releasing intrauterine system (LNG-IUS): Most effective hormonal option for adenomyosis with significant improvement in pain and bleeding 1, 3
    • Combined oral contraceptives: Effective for controlling bleeding symptoms but less effective than LNG-IUS 1
    • Progestins: Dienogest or other progestins can reduce symptoms 2
    • GnRH agonists/antagonists with add-back therapy: Can reduce bleeding and adenomyosis volume by 40-50%; limit use to 3-6 months due to bone mineral density concerns 1, 2
  2. Non-hormonal Options:

    • NSAIDs: Can reduce bleeding by 20-40% and help with pain 1
    • Tranexamic acid: First-line non-hormonal medication for heavy menstrual bleeding; take only during menstruation 1

Step 2: Minimally Invasive Procedures (If Medical Management Fails)

  • Uterine Artery Embolization (UAE):
    • Improves symptoms for up to 7 years with 85-94% symptom improvement
    • Particularly effective when fibroids predominate alongside adenomyosis 1
    • Consider for women not desiring future fertility

Step 3: Surgical Options (For Refractory Cases)

  • Endometrial ablation: Option for women with primarily bleeding symptoms who have completed childbearing 2
  • Excision of adenomyosis: Conservative surgical option for focal adenomyosis in women desiring fertility preservation 2, 6
  • Hysterectomy: Definitive treatment for women who have completed childbearing and have failed other therapies 2, 3, 6

Special Considerations for a 46-Year-Old Patient

  1. Proximity to menopause: At 46, the patient is approaching menopause, which may influence treatment decisions. Consider less invasive options if symptoms are likely to resolve with natural menopause in the near future.

  2. Fertility desires: If fertility is no longer desired, more definitive treatment options can be considered.

  3. Coexisting conditions: Adenomyosis frequently coexists with endometriosis and uterine fibroids, which may require additional treatment considerations 7, 6.

  4. Treatment monitoring: Follow hemoglobin levels to ensure anemia is resolving and monitor adenomyosis size with imaging before and after treatment 1.

Pitfalls to Avoid

  • Inadequate pain control: Don't undertreat pain; combine analgesics with hormonal therapies when needed.
  • Delayed definitive treatment: Don't prolong ineffective medical management if quality of life is significantly impacted.
  • Overlooking coexisting conditions: Adenomyosis frequently coexists with endometriosis and fibroids; ensure comprehensive evaluation 6.
  • Prolonged GnRH agonist use: Limit to 3-6 months due to bone mineral density loss and other side effects 1.

By following this algorithmic approach, the 46-year-old patient with adenomyosis-related pelvic pain can receive appropriate treatment that balances symptom relief with consideration of her life stage and individual needs.

References

Guideline

Uterine Fibroid Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Guideline No. 437: Diagnosis and Management of Adenomyosis.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2023

Research

Adenomyosis: Diagnosis and Management.

American family physician, 2022

Research

The sonographic diagnosis of adenomyosis.

Ultrasound quarterly, 2005

Research

Adenomyosis: A Sonographic Diagnosis.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.